A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot Testing

Completed

Conditions studied: Cancer Survivors, Statin Use Among High Risk Survivors

In brief

The purpose of this study is to collect initial data on what survivors of childhood, adolescent, and young adult cancer think of how information about statins is communicated. Statins are medications that lower cholesterol. The results of this study will be used to improve the communication about statins. This is to aid patients and their providers in making health care decisions together, also known as shared decision making.

Key facts

Study ID

NCT02895880

Run by

Memorial Sloan Kettering Cancer Center

People needed

49

Starts

2016-08-01

Expected to finish

2020-06-11

Last updated by the study team

2020-06-16

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• English speaking
• A personal history of cancer, tumor, or a related illness
• Followed in the Adult Long Term Follow Up Program
• Received ≥ 2000 cGy radiation to the heart/chest
• ≥Ten years post-radiation therapy to the heart/chest
• Age ≥ 25 years old

You may not qualify if…

• Evidence of active progression of disease or recurrence
• Neurocognitive deficits that impair ability to give informed consent
• Current use of a statin
• Diagnosis of another primary cancer for which the patient is currently undergoing radiation therapy chemotherapy, or bone marrow transplant
• Diagnosis of CVD with or without current statin use

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.